Chardan Capital Has Lowered Expectations for Solid Biosciences (NASDAQ:SLDB) Stock Price
Solid Biosciences (NASDAQ:SLDB – Get Free Report) had its price objective decreased by stock analysts at Chardan Capital from $16.00 to $15.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Chardan Capital’s target price points to a potential upside of 408.47% from the stock’s current […]
Solid Biosciences (NASDAQ:SLDB – Get Free Report) had its price objective decreased by stock analysts at Chardan Capital from $16.00 to $15.00 in a research note issued on Monday,Benzinga reports. The brokerage presently has a “buy” rating on the stock. Chardan Capital’s target price points to a potential upside of 408.47% from the stock’s current […]
